Back to ROYAL LONDON ASSET MANAGEMENT LTD ROYAL LONDON ASSET MANAGEMENT LTD

HALOHALO
6 quarters

Position history for ROYAL LONDON ASSET MANAGEMENT LTDROYAL LONDON ASSET MANAGEMENT LTD's holdings in HALOZYME THERAPEUTICS INC

ROYAL LONDON ASSET MANAGEMENT LTD holds 1.8M shares of HALO (HALOZYME THERAPEUTICS INC), worth $141.7M as of 2026-Q2. The position was increased (+12.4% shares). HALO represents 0.3% of ROYAL LONDON ASSET MANAGEMENT LTD's portfolio.

Current Value

$141.7M

Current Shares

1.8M

Total Value Change

+$110.1M

Total Shares Change

+1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.8M
+12.4%
$141.7M0.3%$78.27
41
2026-Q1
Increased
1.6M
+17.4%
$104.1M0.2%$69.40
42
2025-Q4
Increased
1.4M
+19.9%
$92.3M0.2%$67.70
42
2025-Q3
Increased
1.1M
+3.8%
$83.8M0.2%$73.29
37
2025-Q2
Increased
1.1M
+122.3%
$57.3M0.1%$52.21
57
2025-Q1
New
495,676
-
$31.6M0.1%$63.84
40

Other major holders of HALO: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used